Diffuse large B-cell lymphoma in an adolescent female presenting with Epstein-Barr virus-driven hemophagocytic lymphohistiocytosis: A case report

Journal of Medical Case Reports

Volumn 6, Issue , 2012, Pages

  Altaf, Sadaf ^a   Atreaga, Grace M ^a   Joshi, Avni Y ^a   Rodriguez, Vilmarie ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CAPSID PROTEIN; CD68 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEXAMETHASONE; DOXORUBICIN; EPSTEIN BARR VIRUS ANTIGEN; ETOPOSIDE; FERRITIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MERCAPTOPURINE; PREDNISONE; RITUXIMAB; TRIACYLGLYCEROL; VINCRISTINE;

ADOLESCENT; ARTICLE; BLOOD CLOTTING; BONE MARROW BIOPSY; CASE REPORT; CELL INFILTRATION; CERVICAL LYMPHADENOPATHY; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; CRITICAL ILLNESS; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; GENETIC SCREENING; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HISTIOCYTE; HUMAN; HUMAN TISSUE; HYPERBILIRUBINEMIA; HYPERTRANSAMINASEMIA; IMMUNOSUPPRESSIVE TREATMENT; JAUNDICE; LABORATORY TEST; LARGE CELL LYMPHOMA; LUMBAR PUNCTURE; MACROPHAGE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PANCYTOPENIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SEROLOGY; TREATMENT OUTCOME; VIRUS REACTIVATION;

EID: 84864671236     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-6-141     Document Type: Article

References (15)

1. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Henter JI, Horne A, Aricá M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G, Pediatr Blood Cancer 2007 48 124 131 10.1002/pbc.21039 16937360 (Pubitemid 44958267)
2. Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Clementi R, Emmi L, Maccario R, Liotta F, Moretta L, Danesino C, Aricá M, Blood 2002 100 2266 2267 10.1182/blood-2002-04-1030 12229880 (Pubitemid 35001269)
3. Infection- and malignancy-associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Janka G, Imashuku S, Elinder G, Schneider M, Henter JI, Hematol Oncol Clin North Am 1998 12 435 444 10.1016/S0889-8588(05) 70521-9 9561911 (Pubitemid 28175891)
4. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Allen CE, Yu X, Kozinetz CA, McClain KL, Pediatr Blood Cancer 2008 50 1227 1235 10.1002/pbc.21423 18085676 (Pubitemid 351555548)
5. Hemophagocytic syndromes and infection. Fisman DN, Emerg Infect Dis 2000 6 601 608 10.3201/eid0606.000608 11076718 (Pubitemid 32110502)
6. Hemophagocytic syndrome in an adolescent with Crohn disease receiving azathioprine and infliximab. Francolla KA, Altman A, Sylvester FA, J Pediatr Gastroenterol Nutr 2008 47 193 195 10.1097/MPG.0b013e31816a30b9 18664872
7. Association of Crohns disease, thiopurines, and primary epstein-barr virus infection with hemophagocytic lymphohistiocytosis. Biank VF, Sheth MK, Talano J, Margolis D, Simpson P, Kugathasan S, Stephens M, J Pediatr 2011 159 808 812 10.1016/j.jpeds.2011.04.045 21722918
8. Clinicopathological spectrum of haemophagocytic syndrome in Epstein-Barr virus-associated peripheral T-cell lymphoma. Yao M, Cheng AL, Su IJ, Lin MT, Uen WC, Tien HF, Wang CH, Chen YC, Br J Haematol 1994 87 535 543 10.1111/j.1365-2141.1994.tb08309.x 7993793 (Pubitemid 24230019)
9. Subcutaneous T-cell lymphoma with associated hemophagocytic syndrome and terminal leukemic transformation. Romero LS, Goltz RW, Nagi C, Shin SS, Ho AD, J Am Acad Dermatol 1996 34 904 910 10.1016/S0190-9622(96)90077-8 8621826 (Pubitemid 26143879)
10. Hemophagocytic lymphohistiocytosis onset during induction therapy for precursor B-cell acute lymphoblastic leukemia. Breakey VR, Abdelhaleem M, Weitzman S, Abla O, J Pediatr Hematol Oncol 2008 30 956 958 10.1097/MPH. 0b013e3181864ab9 19131791
11. Intravascular large B-cell lymphoma: the heterogeneous clinical manifestations of its classical and hemophagocytosis-related forms. Nakamura S, Murase T, Kinoshita T, Haematologica 2007 92 434 436 10.3324/haematol.11372 17488652 (Pubitemid 350144287)
12. Childhood non-Hodgkin lymphoma presenting as hemophagocytic syndrome. Blatt J, Weston B, Belhorn T, Hamrick H, Maia D, Pediatr Hematol Oncol 2002 19 45 49 10.1080/088800102753356185 11787866 (Pubitemid 34665493)
13. Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. Huck K, Feyen O, Niehues T, Rüschendorf F, Hübner N, Laws HJ, Telieps T, Knapp S, Wacker HH, Meindl A, Jumaa H, Borkhardt A, J Clin Invest 2009 119 1350 1358 10.1172/JCI37901 19425169
14. Using flow cytometry to screen patients for X-linked lymphoproliferative disease due to SAP deficiency and XIAP deficiency. Marsh RA, Bleesing JJ, Filipovich AH, J Immunol Methods 2010 362 1 9 10.1016/j.jim.2010.08.010 20816973
15. Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis. Menasche G, Feldmann J, Fischer A, de Saint Basile G, Immunol Rev 2005 203 165 179 10.1111/j.0105-2896.2005.00224.x 15661029 (Pubitemid 40179701)